Search research articles
Contact Us
Filters
Showing results (521-530 of 557) with videos related to
Page
of 56
Sort By:
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Mbio
|
September 22, 2022
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Luther A Bartelt, Alena J Markmann, Bridget Nelson, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures
Kenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Nature
|
August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Kenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Journal of Medicinal Chemistry
|
November 13, 2013
Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators
Nandini C Patel, Jacob Schwarz, Xinjun J Hou, et al.
Msphere
|
August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Journal of Viral Hepatitis
|
October 29, 2017
Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study
X Liang, Q Xie, D Tan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 557) with videos related to
Sort By:
Page
of 56
Journal of Proteome Research
|
August 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert, et al.
Mbio
|
September 22, 2022
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Luther A Bartelt, Alena J Markmann, Bridget Nelson, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures
Kenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Nature
|
August 28, 2020
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Kenneth H Dinnon, Sarah R Leist, Alexandra Schäfer, et al.
Journal of Medicinal Chemistry
|
November 13, 2013
Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators
Nandini C Patel, Jacob Schwarz, Xinjun J Hou, et al.
Msphere
|
August 25, 2021
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 10, 2021
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
Alena J Markmann, Natasa Giallourou, D Ryan Bhowmik, et al.
Journal of Viral Hepatitis
|
October 29, 2017
Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study
X Liang, Q Xie, D Tan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
Page
of 56